Abstract
Non-deprived rats were familiarised with a highly palatable diet until baseline consumption in a 60-min daily access period had stabilised. The benzodiazepine receptor agonist midazolam (1.25–10.0 mg/kg, IP) produced a large, dose-related increase in food consumption during the first 30 min of access. It also produced significant, short-term hyperphagia in animals which had been partially pre-satiated on the diet before drug administration, an effect which was reversible by the benzodiazepine receptor antagonist Ro15-1788. Administered alone, Ro15-1788 (1.25–10.0 mg/kg, IP) had no intrinsic activity in the food consumption test. In contrast, CGS 8216 (2.5–40.0 mg/kg, IP) produced a marked dose-related suppression of food intake. This anorectic effect was shared by two benzodiazepine receptor inverse agonists, FG 7142 and DMCM, which also produced dose-dependent reductions in consumption. The effects on feeding produced by FG 7142 (20 mg/kg, IP) and DMCM (1.25 mg/kg, IP) were reversed by either Ro15-1788 (2.5 and 5.0 mg/kg) or midazolam (5.0 and 10.0 mg/kg). A matched anorectic effect produced by CGS 8216 (40 mg/kg) was not, however, reversed by either Ro15-1788 or midazolam. This suggests that at a high dose CGS 8216 may act by a mechanism different from that of the two inverse agonists. The feeding test described in the report proved sensitive to both hyperphagic and anorectic effects of drugs active at benzodiazepine receptors, pointing to a possible bi-directional control of palatable food consumption.
Similar content being viewed by others
References
Baile CA, McLaughlin CL (1979) A review of the behavioral and physiological responses to elfazepam, a chemical feed intake stimulant. J Anim Sci 49:1371–1395
Bennett DA, Petrack B (1984) CGS 9896: a nonbenzodiazepine, nonsedating potential anxiolytic. Drug Dev Res 4:75–82
Boast CA, Bernard PS, Barbaz BS, Bergen KM (1983) The neuropharmacology of various diazepam antagonists. Neuropharmacology 22:1511–1521
Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu ER, Muller RKM, Haefely W (1982) Benzodiazepine antagonist Ro15-1788; neurological and behavioral effects. Psychopharmacology 78:8–18
Braestrup C, Schmiechen R, Neef G, Nielsen M, Petersen EN (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216:1241–1243
Braestrup C, Nielsen M, Honoré T, Jensen LH, Petersen EN (1983). Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology 22:1451–1457
Cooper SJ (1980) Benzodiazepines as appetite-enhancing compounds. Appetite 1:7–19
Cooper SJ (1982) Specific benzodiazepine antagonist Ro15-1788 and thirst-induced drinking in the rat. Neuropharmacology 21:483–486
Cooper SJ (1985) Neuropeptides and food and water intake. In: Sandler M, Silverstone T (eds) Psychopharmacology and food. Oxford University Press, Oxford (in press)
Cooper SJ, Estall LB (1985) Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors. Neurosci Biobehav Rev 9:5–19
Cooper SJ, Gilbert DB (1985) Clonazepam-induced hyperphagia in nondeprived rats: tests of pharmacological specificity with Ro5-4864, Ro5-3663, Ro15-1788 and CGS 9896. Pharmacol Biochem Behav (in press)
Cooper SJ, Moores WR (1985) Benzodiazepine-induced hyperphagia in the nondeprived rat: Comparisons with CL 218, 872, zopiclone, tracazolate and phenobarbital. Pharmacol Biochem Behav (in press)
Corda MG, Blaker WD, Mendelson WD, Gudotti A, Costa E (1983) β-carbolines enhance shock-induced suppression of drinking in rats. Proc nat Acad Sci USA 80:2072–2076
Czernick AJ, Petrack B, Kalinsky HJ, Psychoyos, S, Cash WD, Tsai C, Rinchart RK, Granat FG, Lovell RA, Brundish DE, Wade R (1982) CGS 8216: receptor binding characteristics of a poent benzodiazepine antagonist. Life Sci 30:363–372
Dantzer R, Pério A (1982) Behavioural evidence for partial agonist properties of Ro15-1788, a benzodiazepine receptor antagonist. Eur J Pharmacol 81:655–658
Denenberg VH (1984) Some statistical and experimental considerations in the use of the analysis-of-variance procedure. Am J Physiol 246:R403-R408
Falk JL, Tang M (1984) Midazolam-induced increase in NaCl solution ingestion: differential effect of the benzodiazepine antagonist Ro15-1788 and CGS 8216. Pharmacol Biochem Behav 21:965–968
Feldon J, Lerner T, Levin D, Myslobodsky M (1983) A behavioral examination of convulsant benzodiazepine and GABA antagonist, Ro5-3663, and benzodiazepine-receptor antagonist Ro15-1788. Pharmacol Biochem Behav 19:39–41
File SE, Cooper SJ (1985) Benzodiazepines and behavior. Neurosci Biobehav Rev 9:1–3
File SE, Lister RG (1983a) Interactions of ethyl-β-carboline-3-carboxylate and Ro15-1788 with CGS 8216 in an animal model of anxiety. Neurosci Lett 39:91–94
File SE, Lister RG (1983b) Quinolines and anxiety: anxiogenic effects of CGS 8216 and partial anxiolytic profile of PK 9084. Pharmacol Biochem Behav 18:185–188
File SE, Lister RG, Nutt DJ (1982a) Intrinsic actions of benzodiazepine antagonists. Neurosci Lett 32:165–168
File SE, Lister RG, Nutt DJ (1982b) The anxiogenic action of benzodiazepine antagonists. Neuropharmacology 21:1033–1037
File SE, Pellow S (1984) The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro15-1788 but not by CGS 8216. Arch Int Pharmacodyn Ther 271:198–205
Fung SC, Fillenz M (1984) Multiple effects of drugs acting on benzodiazepine receptors. Neurosci Lett 50:203–207
Gibbs J, Smith GP (1984) The neuroendocrinology of postprandial satiety. In: Martini L, Ganong WF (eds) Frontiers in neuroendocrinology, volume 8. Raven Press, New York, pp 223–245
Goldberg ME, Salama AI, Patel JB, Malick JB (1983) Novel nonbenzodiazepine anxiolytics. Neuropharmacology 22:1499–1504
Honoré T, Nielsen M, Braestrup C (1983) Binding of 3H-DMCM to benzodiazepine receptors; chloride dependent allosteric regulation mechanisms. J Neural Transm 58:83–98
Hunkeler W, Möhler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290:514–516
Jensen LH, Petersen EN (1983) Bidirectional effects of benzodiazepine receptor ligands against picrotoxin-and pentylenetetrazol-induced seizures. J Neural Transm 58:183–191
Kaijima M, La Gal la Salle G, Rossier J (1983) The partial benzodiazepine agonist properties of Ro15-1788 in pentylenetetrazol-induced seizures in cats. Eur J Pharmacol 93:113–115
Lippa AS, Coupet J, Greenblatt EN, Klepner CA, Beer B (1979) A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety. Pharmacol Biochem Behav 11:99–106
Locke KW, Brown DR, Holtzman SG (1982) Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey. Pharmacol Biochem Behav 17:1275–1279
Mansbach RS, Stanley JA, Barrett JE (1984) Ro15-1788 and β-CCE selectively eliminate diazepam-induced feeding in the rabbit. Pharmacol Biochem Behav 20:763–766
Margules DL, Stein L (1967) Neuroleptics vs. tranquilizers: evidence from animal behavior studies of mode and site of action. In: Brill H, Cole JO, Deniker, P, Hippius H, Bradley PB (eds) Neuropsychopharmacology. Excerpta Medical Foundation, Amsterdam, pp 108–120
Mereu GP, Fratta W, Chessa P, Gessa GL (1976) Voraciousness induced in cats by benzodiazepines. Psychopharmacology 47:101–103
Nutt DJ (1983) Pharmacological and behavioural studies on benzodiazepine antagonists and contragonists. In: Biggio G, Costa E (eds) Benzodiazepine recognition site ligands: biochemistry and pharmacology. Raven press, New York, pp 153–173
Patel JB, Malick JB (1982) Pharmacological properties of tracazolate: a new non-benzodiazepine anxiolytic agent. Eur J Pharmacol 78:323–333
Pellow S, File SE (1984) Minireview. Behvioural actions of Ro5-4864: a peripheral-type benzodiazepine? Life Sci 35:229–240
Pellow S, File SE, Herberg LJ (1984) Intracranial self-stimulation distinguishes between two benzodiazepine antagonists. Neurosci Lett 47:173–177
Petersen EN (1983) DMCM: a potent convulsive benzodiazepine receptor ligand. Eur J Pharmacol 94:117–124
Petersen EN, Jensen LH, Honoré T, Braestrup C (1983) Differential pharmacological effects of benzodiazepine receptor inverse agonists. In: Biggio G, Costa E (eds) Benzodiazepine recognition site ligands: biochemistry and pharmacology. Raven Press, New York, pp 57–64
Pieri L, Schaffner R, Scherschlicht R, Polc P, Sepinwall J, Davidson A, Möhler H, Cumin R, DaPrada M, Burkard WP, Keller HH, Müller RKM, Gerold M, Pieri M, Cook L, Haefely W (1981) Pharmacology of midazolam. Arzneim-Forsch 31:2180–2201
Polc P, Laurent J-P, Scherschlicht R, Haefely W (1981) Electrophysiological studies on the specific benzodiazepine antagonist Ro15-1788. Naunyn-Schmiedeberg's Arch Pharmacol 316:317–325
Polc P, Bonetti EP, Schaffner R, Haefely W (1982) A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro15-1788, benzodiazepine tranquillizers, β-carbolines and phenobarbitone. Naunyn-Schmiedeberg's Arch Pharmacol 321:260–264
Rodgers RJ, Waters AJ, Rosenfield S (1983) Evidence for intrinsic behavioural activity of the benzodiazepine antagonist, Ro15-1788, in male mice. Pharmacol Biochem Behav 19:895–898
Skerritt JH, Macdonald RL (1983) Benzodiazepine Ro15-1788: electrophysiological evidence for partial agonist activity. Neurosci Lett 43:321–326
Tang M, Soroka S, Falk JL (1983) Agonistic action of a benzodiazepine antagonist: effects: effects of Ro15-1788 and midazolam on hypertonic NaCl intake. Pharmacol Biochem Behav 18:953–955
Turkish S, Cooper SJ (1984) Enhancement of saline consumption by chlordiazepoxide in thirsty rats: antagonism by Ro15-1788. Pharmacol Biochem Behav 20:869–873
Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York
Wise RA, Dawson V (1974) Diazepam-induced eating and lever pressing for food in satiated rats. J Comp Physiol Psychol 86:930–941
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cooper, S.J., Barber, D.J., Gilbert, D.B. et al. Benzodiazepine receptor ligands and the consumption of a highly palatable diet in non-deprived male rats. Psychopharmacology 86, 348–355 (1985). https://doi.org/10.1007/BF00432227
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432227